Allarity Therapeutics ALLR
NASDAQ ALLR
$0.97 +0.01 (+0.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Research & Development (2020 - 2026)

Updated

Allarity Therapeutics (ALLR) recorded Research & Development of $1.35 million in Q2 2026, down 42.1% from $2.32 million a year earlier but up 3.7% from the prior quarter.

Analysis

Allarity Therapeutics (ALLR) Research & Development (2020 - 2026) Analysis & Trends

On a TTM basis, Allarity Therapeutics' Research & Development came in at $5.52 million as of Jun 30, 2026, down 16.3% year-over-year; for FY2025, it came in at $6.6 million, up 8.3% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $6.1 million in FY2024 (-14.2%), $7.1 million in FY2023 (+2.5%), $6.93 million in FY2022 (-51.2%) and $14.2 million in FY2021 (+236.6%).
  • Quarterly Research & Development has ranged from $941,000 in Q4 2022 to $9.52 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Research & Development has declined for three consecutive quarters, with an average decline of 4.3% over the last eight quarters.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 471.5% in Q4 2021, against a decline of 90.1% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.3 million (Q1 2026), $1.67 million (Q4 2025) and $1.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Allarity Therapeutics 1.56 Mn 1.56 Mn - 1.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.35 Mn
Mar 31, 2026 1.30 Mn
Dec 31, 2025 1.67 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 2.32 Mn
Mar 31, 2025 1.40 Mn
Dec 31, 2024 1.85 Mn
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.06 Mn
Mar 31, 2024 2.17 Mn
Dec 31, 2023 2.62 Mn
Sep 30, 2023 1.95 Mn
Jun 30, 2023 1.11 Mn
Mar 31, 2023 1.43 Mn
Dec 31, 2022 941,000.00
Sep 30, 2022 3.00 Mn
Jun 30, 2022 1.70 Mn
Mar 31, 2022 1.29 Mn
Dec 31, 2021 9.52 Mn
Sep 30, 2021 1.36 Mn
API Access

Allarity Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ALLR&period=max&api_key=YOUR_API_KEY